Aurobindo Pharma to invest Rs 5.38 crore each in 2 solar power firms
New Delhi: Aurobindo Pharma on Tuesday said it has inked a pact to acquire 26 per cent stake each in two Hyderabad-based solar power generating companies.
The drug firm has entered into binding agreements to invest Rs 5.38 crore each in NVNR (Ramannapet I) Power Plant Pvt Ltd and NVNR (Ramannapet II) Power Plant Pvt Ltd, aggregating to Rs 10.76 crore, Aurobindo Pharma said in a regulatory filing.
The company has invested in the two firms to avail the benefit of captive consumption of solar power, it added.
"After making the said investments, the company will be holding 26 per cent of the share capital in each of the aforesaid solar power generating companies," Aurobindo Pharma noted.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.